MediSieve receives £102,000 funding for malaria device

MediSieve, the developer of a magnetic filter device that treats malaria by capturing and removing malaria infected red blood cells, has received a Pathfinder Award from the Wellcome Trust

The award provides MediSieve with £102,000 to fund a 12-month project to manufacture and test clinical prototypes of its device.

To secure the award, MediSieve had to show that it could perform discrete high-quality experiments to demonstrate proof-of-concept data assay development and facilitate product development that could improve the outlook for patients with orphan and neglected diseases.

The Wellcome Trust is an independent global charitable foundation and the aim of the project is to prove the device is safe for use on human patients according to MediSieve.

Dr George Frodsham, founder of MediSieve, said: “We’re delighted to get this Pathfinder Award. It means we can take a huge step forward with our project and build our relationship with the Wellcome Trust.

“We can now produce the clinical version of our device in preparation for pre-clinical studies.”

MediSieve’s Pathfinder Award comes less than six months after the company secured £350,000 in seed funding to develop its device.

Treatment with MediSieve’s magnetic filter device offers new hope for malaria patients whose cases are severe or resistant to existing medicines as it involves no drugs or chemicals.

Initial trials show that the 3D printed magnetic blood filter could extract up to 90% of infected cells from a person with malaria in under four hours.

Red blood cells infected with a malaria parasite have magnetic properties. This enables MediSieve’s device to capture them without affecting healthy cells. The process is similar to dialysis in that infected cells are captured as blood passes through an external loop.  Rapid removal of infected cells has the potential to reduce symptoms, severity and mortality.

Frodsham said: “This device is the first of its kind to treat diseases this way. It is a fundamentally different approach to anything that’s been done before.”

This treatment could be used when drugs become ineffective or to supplement existing drug treatments. The magnetic device could help patients manage malaria and keep symptoms at bay indefinitely.

MediSieve said its breakthrough comes at a time when scientists are increasingly concerned about drug resistant strains of malaria.